Pacira BioSciences SG&A Expense (Quarterly) Analysis

Pacira BioSciences Inc (PCRX)

27.21 -0.11 (-0.40%) USD | NASDAQ | May 03, 16:00

27.22 +0.01 (+0.04%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2009. Upgrade now.

Date	Value
December 31, 2023	65.80M
September 30, 2023	67.95M
June 30, 2023	64.85M
March 31, 2023	70.84M
December 31, 2022	63.97M
September 30, 2022	61.28M
June 30, 2022	65.00M
March 31, 2022	64.26M
December 31, 2021	52.15M
September 30, 2021	47.86M
June 30, 2021	50.81M
March 31, 2021	48.52M
December 31, 2020	52.83M
September 30, 2020	52.56M
June 30, 2020	43.34M
March 31, 2020	44.78M
December 31, 2019	54.22M
September 30, 2019	50.13M
June 30, 2019	49.13M
March 31, 2019	47.30M
December 31, 2018	44.65M
September 30, 2018	44.18M
June 30, 2018	44.25M
March 31, 2018	44.19M
December 31, 2017	39.18M

Date	Value
September 30, 2017	40.64M
June 30, 2017	39.55M
March 31, 2017	42.12M
December 31, 2016	34.67M
September 30, 2016	36.31M
June 30, 2016	43.67M
March 31, 2016	37.96M
December 31, 2015	37.55M
September 30, 2015	35.31M
June 30, 2015	34.75M
March 31, 2015	31.43M
December 31, 2014	31.02M
September 30, 2014	28.22M
June 30, 2014	24.84M
March 31, 2014	22.59M
December 31, 2013	20.17M
September 30, 2013	15.32M
June 30, 2013	14.08M
March 31, 2013	12.94M
December 31, 2012	13.36M
September 30, 2012	11.38M
June 30, 2012	10.41M
March 31, 2012	11.15M
December 31, 2011	7.199M
September 30, 2011	4.972M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

43.34M

Minimum

Jun 2020

70.84M

Maximum

Mar 2023

56.33M

Average

52.83M

Median

Dec 2020

SG&A Expense (Quarterly) Benchmarks